Esperion Therapeutics Aktie

Kaufen
Verkaufen
2,13 EUR +0,10 EUR +4,83 %
2,23 USD +0,05 USD +2,29 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 414,79 Mio. EUR

Div. Rendite 0,00%

WKN A1W1SJ

ISIN US29664W1053

Symbol ESPR


Esperion Therapeutics Aktie Analyse

07.01.19 Esperion Therapeutics Strong Buy Needham & Company, LLC
16.10.18 Esperion Therapeutics Buy BTIG Research
27.03.18 Esperion Therapeutics Neutral Chardan Capital Markets
21.02.18 Esperion Therapeutics Strong Buy Needham & Company, LLC
17.01.18 Esperion Therapeutics Buy UBS AG
14.12.17 Esperion Therapeutics Strong Buy Needham & Company, LLC
06.12.17 Esperion Therapeutics Neutral Chardan Capital Markets
27.06.17 Esperion Therapeutics Buy Stifel, Nicolaus & Co., Inc.
23.06.17 Esperion Therapeutics Buy Deutsche Bank AG
30.03.17 Esperion Therapeutics Buy UBS AG
23.02.17 Esperion Therapeutics Sector Perform RBC Capital Markets
05.07.16 Esperion Therapeutics Hold WallachBeth
30.06.16 Esperion Therapeutics Buy Needham & Company, LLC
29.06.16 Esperion Therapeutics Sector Perform RBC Capital Markets
26.02.16 Esperion Therapeutics Neutral Chardan Capital Markets
25.02.16 Esperion Therapeutics Buy Stifel, Nicolaus & Co., Inc.
15.12.15 Esperion Therapeutics Outperform RBC Capital Markets
26.10.15 Esperion Therapeutics Buy Lake Street
26.10.15 Esperion Therapeutics Buy WallachBeth
29.09.15 Esperion Therapeutics Sell Chardan Capital Markets
31.08.15 Esperion Therapeutics Sell Chardan Capital Markets
19.08.15 Esperion Therapeutics Buy Needham & Company, LLC
10.08.15 Esperion Therapeutics Strong Buy Needham & Company, LLC
07.08.15 Esperion Therapeutics Sell Chardan Capital Markets
31.07.15 Esperion Therapeutics Sell Chardan Capital Markets
27.07.15 Esperion Therapeutics Sell Chardan Capital Markets
08.07.15 Esperion Therapeutics Sell Chardan Capital Markets
10.06.15 Esperion Therapeutics Sell Chardan Capital Markets
22.05.15 Esperion Therapeutics Sell Chardan Capital Markets
21.05.15 Esperion Therapeutics overweight Barclays Capital
08.05.15 Esperion Therapeutics Buy Needham & Company, LLC
08.05.15 Esperion Therapeutics Buy Stifel, Nicolaus & Co., Inc.
23.04.15 Esperion Therapeutics Outperform RBC Capital Markets
01.04.15 Esperion Therapeutics Buy UBS AG
06.03.15 Esperion Therapeutics Buy Needham & Company, LLC
17.02.15 Esperion Therapeutics Buy Stifel, Nicolaus & Co., Inc.
27.10.14 Esperion Therapeutics Buy Needham & Company, LLC